We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+3.46%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.02%
AUM
$80B
AUM Growth
+$3.78B
Cap. Flow
+$2.03B
Cap. Flow %
2.54%
Top 10 Hldgs %
13.93%
Holding
3,241
New
178
Increased
2,105
Reduced
536
Closed
137

Top Buys

Rank Stock Value
1
SPGI icon
S&P Global
SPGI
+$80.9M
2
SCHZ icon
Schwab US Aggregate Bond ETF
SCHZ
+$66M
3
MRK icon
Merck
MRK
+$63.3M
4
PG icon
Procter & Gamble
PG
+$58.4M
5
IBM icon
IBM
IBM
+$54.1M

Sector Composition

Rank Sector Weight
1 Healthcare 13.8%
2 Technology 13.16%
3 Financials 12.69%
4 Industrials 10.65%
5 Consumer Staples 9.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RGLS
2976
DELISTED
Regulus Therapeutics
RGLS
$179K ﹤0.01%
515
+184
+56% +$132K
LSBG
2977
DELISTED
Lake Sunapee Bank Group
LSBG
$178K ﹤0.01%
+10,400
New +$162K
CDTX
2978
DELISTED
Cidara Therapeutics
CDTX
$177K ﹤0.01%
+858
New +$208K
STML
2979
DELISTED
Stemline Therapeutics, Inc.
STML
$177K ﹤0.01%
26,000
-2,000
-7% -$12.6K
EGLT
2980
DELISTED
Egalet Corporation
EGLT
$177K ﹤0.01%
+35,600
New +$211K
TBRA
2981
DELISTED
Tobira Therapeutics, Inc. Common Stock
TBRA
$177K ﹤0.01%
+14,029
New +$131K
ASXC
2982
DELISTED
Asensus Surgical, Inc.
ASXC
$176K ﹤0.01%
11,054
+6,969
+171% +$219K
WG
2983
DELISTED
Willbros Group
WG
$176K ﹤0.01%
+69,500
New +$192K
LUB
2984
DELISTED
Luby's Inc.
LUB
$174K ﹤0.01%
+34,600
New +$171K
PARAA
2985
DELISTED
Paramount Global Class A
PARAA
$173K ﹤0.01%
+2,992
New +$174K
ACGN
2986
DELISTED
Aceragen Inc
ACGN
$172K ﹤0.01%
824
TTOO
2987
DELISTED
T2 Biosystems, Inc
TTOO
$171K ﹤0.01%
4
ESSA
2988
DELISTED
ESSA Bancorp
ESSA
$168K ﹤0.01%
+12,500
New +$169K
MCFT icon
2989
MasterCraft Boat Holdings
MCFT
$588M
$168K ﹤0.01%
15,200
AMSC icon
2990
American Superconductor
AMSC
$1.55B
$167K ﹤0.01%
+19,720
New +$184K
GIFI
2991
DELISTED
Gulf Island Fabrication
GIFI
$165K ﹤0.01%
23,774
+630
+3% +$4.51K
TTNP
2992
DELISTED
Titan Pharmaceuticals
TTNP
$165K ﹤0.01%
+8
New +$170K
SEMI
2993
DELISTED
SunEdison Semiconductor Limited
SEMI
$163K ﹤0.01%
27,419
-55,472
-67% -$307K
RLH
2994
DELISTED
Red Lions Hotel Corporation
RLH
$162K ﹤0.01%
+22,200
New +$172K
CRDF icon
2995
Cardiff Oncology
CRDF
$77M
$161K ﹤0.01%
491
BREW
2996
DELISTED
Craft Brew Alliance, Inc.
BREW
$161K ﹤0.01%
13,900
ANTH
2997
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
$161K ﹤0.01%
6,492
MOBL
2998
DELISTED
MobileIron, Inc.
MOBL
$161K ﹤0.01%
52,736
NMRX
2999
DELISTED
Numerex Corp
NMRX
$161K ﹤0.01%
+21,400
New +$157K
QNST icon
3000
QuinStreet
QNST
$1.23B
$160K ﹤0.01%
44,900
-20,184
-31% -$68.9K

Similar funds

Charles Schwab's Q2 2016 Portfolio in Review

As of Q2 2016, Charles Schwab held 3,241 positions worth $80B, up 5% from $76.2B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Charles Schwab's Q2 2016 filing shows 178 new, 2,105 increased, 536 reduced and 137 closed positions. Its largest new stake was S&P Global: 753,915 shares worth $80.9M. The largest sale was TIME WARNER CABLE INC NEW COM STK, an estimated $178M.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 14% a quarter earlier, followed by Technology and Financials.

  • Charles Schwab's largest Q2 2016 buy was S&P Global: 753,915 shares worth $80.9M.
  • Charles Schwab added most to Merck in Q2 2016, an estimated $63.3M increase.
  • Charles Schwab's biggest Q2 2016 reduction was Computer Sciences, cutting an estimated $61.8M.
  • Charles Schwab fully exited TIME WARNER CABLE INC NEW COM STK in Q2 2016, selling an estimated $178M.
  • Charles Schwab's ten largest holdings make up 14% of its $80B portfolio in Q2 2016.
  • Charles Schwab opened 178 new positions and closed 137 in Q2 2016.
  • Charles Schwab's portfolio value rose 5% quarter-over-quarter to $80B.

Based on Charles Schwab's 13F filing for Q2 2016, filed 15 Aug 2016.